- Home
- TYGO vs CCEL Comparison
TYGO vs CCEL Comparison
Compare TYGO & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TYGO
- CCEL
- Stock Information
- Founded
- TYGO 2007
- CCEL 1989
- Country
- TYGO United States
- CCEL United States
- Employees
- TYGO N/A
- CCEL N/A
- Industry
- TYGO Semiconductors
- CCEL Managed Health Care
- Sector
- TYGO Technology
- CCEL Health Care
- Exchange
- TYGO Nasdaq
- CCEL Nasdaq
- Market Cap
- TYGO 45.8M
- CCEL 51.9M
- IPO Year
- TYGO N/A
- CCEL 1997
- Fundamental
- Price
- TYGO $0.80
- CCEL $5.82
- Analyst Decision
- TYGO Buy
- CCEL Strong Buy
- Analyst Count
- TYGO 3
- CCEL 1
- Target Price
- TYGO $3.00
- CCEL $8.50
- AVG Volume (30 Days)
- TYGO 25.6K
- CCEL 11.7K
- Earning Date
- TYGO 05-13-2025
- CCEL 04-15-2025
- Dividend Yield
- TYGO N/A
- CCEL 4.27%
- EPS Growth
- TYGO N/A
- CCEL N/A
- EPS
- TYGO N/A
- CCEL 0.01
- Revenue
- TYGO $54,014,000.00
- CCEL $32,102,750.00
- Revenue This Year
- TYGO $61.65
- CCEL $2.21
- Revenue Next Year
- TYGO $28.03
- CCEL $0.98
- P/E Ratio
- TYGO N/A
- CCEL $365.46
- Revenue Growth
- TYGO N/A
- CCEL 2.33
- 52 Week Low
- TYGO $0.58
- CCEL $4.96
- 52 Week High
- TYGO $1.85
- CCEL $9.50
- Technical
- Relative Strength Index (RSI)
- TYGO 47.55
- CCEL 44.23
- Support Level
- TYGO $0.70
- CCEL $5.37
- Resistance Level
- TYGO $0.84
- CCEL $5.70
- Average True Range (ATR)
- TYGO 0.11
- CCEL 0.46
- MACD
- TYGO 0.00
- CCEL 0.03
- Stochastic Oscillator
- TYGO 58.54
- CCEL 50.89
About TYGO Tigo Energy Inc.
Tigo Energy Inc designs solar power conversion and storage products that provide customers with more choice and flexibility. Its mission is to deliver smart hardware and software solutions that enhance safety, increase energy yield, and lower operating costs of residential, commercial, and utility-scale solar systems. Geographically the company generates revenue from EMEA, Americas, and APAC.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.